Value proposition
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary CareOriginal language
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care
Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care
https://www.ipsen.com/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | ENNOVIA SARL greentech, Industrial Machinery Manufacturing, cleantech, manufacturing, industry 4.0 | Other 14 Feb 2024 | | |
 | Alliance maladies rares Non-profit Organizations, healthtech | Other 2 Jun 2024 | | |
 | Evotec Pharmaceutical Manufacturing | Other 15 Nov 2022 | | |
 | The Hope Factory IT Services and IT Consulting, martech, uxtech | Other 20 Jun 2019 | | |
 | CAPZA Venture Capital and Private Equity Principals, fintech | Other 30 Jun 2022 | | |
 | NEUROFIT Research Services, biotech, deeptech | Other 31 Oct 2021 | | |
 | Theranexus Biotechnology Research, biotech, deeptech | Other 31 Jan 2022 | | |
 | Établissement public d'aménagement Paris-Saclay Architecture and Planning | Other 9 Mar 2023 11 Mar 2024 | | |
 | L'Association Française des Managers de la Diversité (AFMD) Civic and Social Organizations, it services | Other 14 Apr 2024 | | |
 | Fonds Clinatec Research Services | Other 11 Apr 2021 16 Nov 2023 | | |